Otto Chemie Pvt. Ltd.

Phone : +91-22-2207 0099
Email : info@ottokemi.com, sales@ottokemi.com


Product Details

DOTA-(Tyr3)-octreotate, puriss, 97%+

DOTATATE, DOTA-octreotate, oxodotreotide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraaza-cyclododec-1-yl]acetyl]- D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L- cysteinyl-,cyclic(2->7) dusulfide, DOTA-octreotate, DOTA-(Tyr3)-octreotate, 2,2',2''-(10-(2-(((R)-1-(((4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-10-(4-aminobutyl)-4-(((1S,2R)-1-carboxy-2-hydroxypropyl)carbamoyl)-16-(4-hydroxybenzyl)-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid xacetate salt

D 4518

GMP

C65H90N14O19S2

29420090

18%

177943-89-4

97%+

1435.63

Vial / Bottle

D 4518 (OTTO) DOTATATE acetate, puriss, 97%+ GMP - used in chemical research.

Precursor for radiolabelled DOTA-TOC Ligand for somatostatin receptors

Properties

Essential chemicals, Research essentials chemicals

97%+

Powder

Colourless to off white

≥80%

≤7.0%

0 - 4°C


Safety Information

Safety Information for this product is unavailable at this time.


PackingsPrice (INR)
50 μg POR
100 μg POR
250 μg POR
1 mg POR

DisclaimerThe above particulars do not release the customer from the obligation to carry out an inspection of goods received.
For laboratory use only. Not for drug, medical, household, or any other unauthorized application.
We assume no liability for misuse or unauthorized application of the product. Please test before use.